Evidence map›Paper›PMID 33055258›Full record

ArticlemSphere2020

Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.

Danielle Barrios Steed, Tiffany Wang, Divyanshu Raheja, Alex D Waldman, Ahmed Babiker, Tanvi Dhere, Colleen S Kraft, Michael H Woodworth

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Carbapenem-resistant bacteria in the environment.Arhiv za higijenu rada i toksikologiju · 2025
    Review
  4. Observational
  5. Article
  6. The Spread of Antibiotic Resistance Genes In Vivo Model.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Danielle Barrios SteedEmory University School of Medicine, Atlanta, Georgia, USA.
Tiffany WangEmory University School of Medicine, Atlanta, Georgia, USA.
Divyanshu RahejaEmory University School of Medicine, Atlanta, Georgia, USA.
Alex D WaldmanEmory University School of Medicine, Atlanta, Georgia, USA.
Ahmed BabikerEmory University School of Medicine, Department of Pathology and Laboratory Medicine, Atlanta, Georgia, USA.ORCID 0000-0003-0578-4871
Tanvi DhereEmory University School of Medicine, Department of Medicine, Division of Digestive Diseases, Atlanta, Georgia, USA.
Colleen S KraftEmory University School of Medicine, Department of Pathology and Laboratory Medicine, Atlanta, Georgia, USA colleen.kraft@emory.edu.ORCID 0000-0003-1757-8477
Michael H WoodworthEmory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia, USA.ORCID 0000-0002-6181-4599
Emory University · US

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008169 · NIGMS · EMORY UNIVERSITY · PI GROSS, ROBERT E · 1987 to 2021
$20.3M
Temporal dynamics of MDRO eradication after FMTK23AI144036 · NIAID · EMORY UNIVERSITY · PI WOODWORTH, MICHAEL HOLMES · 2019 to 2023
$957k
NIAID NIH HHS K23 AI144036NIAID NIH HHS UM1 AI104681NIGMS NIH HHS T32 GM008169
6 · The paper itself

Abstract

Fecal microbiota transplantation (FMT) has promising applications in reducing multidrug-resistant organism (MDRO) colonization and antibiotic resistance (AR) gene abundance. However, data on clinical microbiology results after FMT are limited. We examined the changes in antimicrobial susceptibility profiles in patients with Gram-negative infections in the year before and the year after treatment with FMT for recurrent

Indexed as

Fecal Microbiota TransplantationAgedAged, 80 and overAnti-Bacterial AgentsClostridioides difficileClostridium InfectionsFecesFemaleGastrointestinal MicrobiomeGram-Negative BacteriaHumansMaleMiddle AgedRecurrenceRetrospective StudiesTreatment OutcomeAnti-Bacterial AgentsC. difficile infectionfecal microbiota transplantFMTGram negativeinfectionmicrobiomerecurrent infection

Identifiers

PMID33055258
PMCPMC7565895
OpenAlexW3092863027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.